Factory Mutual Insurance Co. Sells 295,150 Shares of Corteva, Inc. $CTVA

Key Points

• Factory Mutual Insurance Co. decreased its stake in Corteva by 44%, selling 295,150 shares and now holds 375,908 shares (about 0.06% of the company) valued at roughly $25.2 million.
• Analysts remain generally positive with a consensus rating of Moderate Buy (14 Buys, 9 Holds) and a consensus price target of $83.57, with recent upgrades including Jefferies raising its target to $95.
• Corteva matched Q EPS estimates at $0.22 but missed revenue, set FY2026 guidance of 3.450–3.700 EPS, and pays a $0.18 quarterly dividend (annualized yield ~0.9%).

Factory Mutual Insurance Co. decreased its position in Corteva, Inc. (NYSE:CTVA - Free Report) by 44.0% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 375,908 shares of the company's stock after selling 295,150 shares during the period. Factory Mutual Insurance Co. owned about 0.06% of Corteva worth $25,197,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Activest Wealth Management lifted its stake in Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company's stock valued at $25,000 after acquiring an additional 200 shares in the last quarter. JPL Wealth Management LLC acquired a new position in shares of Corteva during the 3rd quarter worth approximately $25,000. True Wealth Design LLC increased its position in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company's stock worth $26,000 after purchasing an additional 264 shares during the last quarter. Total Investment Management Inc. acquired a new position in shares of Corteva during the 2nd quarter worth approximately $27,000. Finally, Redmont Wealth Advisors LLC acquired a new position in shares of Corteva during the 3rd quarter worth approximately $29,000. Institutional investors own 81.54% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Jefferies Financial Group boosted their price target on Corteva from $85.00 to $95.00 and gave the stock a "buy" rating in a research report on Monday, March 2nd. Wolfe Research boosted their price target on Corteva from $81.00 to $86.00 and gave the stock an "outperform" rating in a research report on Thursday, February 5th. Wall Street Zen lowered Corteva from a "buy" rating to a "hold" rating in a research report on Saturday, February 7th. Bank of America boosted their price target on Corteva from $80.00 to $82.00 and gave the stock a "buy" rating in a research report on Thursday, January 8th. Finally, Citigroup boosted their price target on Corteva from $74.00 to $80.00 and gave the stock a "neutral" rating in a research report on Thursday, February 5th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, Corteva presently has an average rating of "Moderate Buy" and a consensus price target of $83.57.

Insider Transactions at Corteva

In related news, insider Brian Titus sold 8,311 shares of the business's stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares in the company, valued at $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.15% of the stock is owned by company insiders.

Corteva Stock Performance

CTVA opened at $83.86 on Friday. The business has a fifty day simple moving average of $78.74 and a 200 day simple moving average of $70.58. The company has a market capitalization of $56.30 billion, a PE ratio of 53.08, a price-to-earnings-growth ratio of 2.85 and a beta of 0.68. Corteva, Inc. has a 1 year low of $57.00 and a 1 year high of $85.63. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm's quarterly revenue was down 1.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were paid a $0.18 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva's payout ratio is 45.57%.

Corteva Company Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.